Determinants of referral of women with urinary incontinence to specialist services: a national cohort study using primary care data from the UK.


Journal

BMC family practice
ISSN: 1471-2296
Titre abrégé: BMC Fam Pract
Pays: England
ID NLM: 100967792

Informations de publication

Date de publication:
16 10 2020
Historique:
received: 11 03 2020
accepted: 08 10 2020
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 25 9 2021
Statut: epublish

Résumé

Female urinary incontinence is underdiagnosed and undertreated in primary care. There is little evidence on factors that determine whether women with urinary incontinence are referred to specialist services. This study aimed to investigate characteristics associated with referrals from primary to specialist secondary care for urinary incontinence. We carried out a cohort study, using primary care data from over 600 general practices contributing to the Clinical Practice Research Datalink (CPRD) in the United Kingdom. We used multi-level logistic regression to estimate adjusted odds ratios (aOR) that reflect the impact of patient and GP practice-level characteristics on referrals to specialist services in secondary care within 30 days of a urinary incontinence diagnosis. All women aged ≥18 years newly diagnosed with urinary incontinence between 1 April 2004 and 31 March 2013 were included. One-year referral was estimated with death as competing event. Of the 104,466 included women (median age: 58 years), 28,476 (27.3%) were referred within 30 days. Referral rates decreased with age (aOR 0.34, 95% CI 0.31-0.37, comparing women aged ≥80 with those aged 40-49 years) and was lower among women who were severely obese (aOR 0.84, 95% CI 0.78-0.90), smokers (aOR 0.94, 95% CI 0.90-0.98), women from a minority-ethnic backgrounds (aOR 0.76, 95% CI 0.65-0.89 comparing Asian with white women), women with pelvic organ prolapse (aOR 0.77, 95% CI 0.68-0.87), and women in Scotland (aOR 0.60, 95% CI 0.46-0.78, comparing women in Scotland and England). One-year referral rate was 34.0% and the pattern of associations with patient characteristics was almost the same as for 30-day referrals. About one in four women with urinary incontinence were referred to specialist secondary care services within one month after a UI diagnosis and one in three within one year. Referral rates decreased with age which confirms concerns that older women with UI are less likely to receive care according to existing clinical guidelines. Referral rates were also lower in women from minority-ethnic backgrounds. These finding may reflect clinicians' beliefs about the appropriateness of referral, differences in women's preferences for treatment, or other factors leading to inequities in referral for urinary incontinence.

Sections du résumé

BACKGROUND
Female urinary incontinence is underdiagnosed and undertreated in primary care. There is little evidence on factors that determine whether women with urinary incontinence are referred to specialist services. This study aimed to investigate characteristics associated with referrals from primary to specialist secondary care for urinary incontinence.
METHODS
We carried out a cohort study, using primary care data from over 600 general practices contributing to the Clinical Practice Research Datalink (CPRD) in the United Kingdom. We used multi-level logistic regression to estimate adjusted odds ratios (aOR) that reflect the impact of patient and GP practice-level characteristics on referrals to specialist services in secondary care within 30 days of a urinary incontinence diagnosis. All women aged ≥18 years newly diagnosed with urinary incontinence between 1 April 2004 and 31 March 2013 were included. One-year referral was estimated with death as competing event.
RESULTS
Of the 104,466 included women (median age: 58 years), 28,476 (27.3%) were referred within 30 days. Referral rates decreased with age (aOR 0.34, 95% CI 0.31-0.37, comparing women aged ≥80 with those aged 40-49 years) and was lower among women who were severely obese (aOR 0.84, 95% CI 0.78-0.90), smokers (aOR 0.94, 95% CI 0.90-0.98), women from a minority-ethnic backgrounds (aOR 0.76, 95% CI 0.65-0.89 comparing Asian with white women), women with pelvic organ prolapse (aOR 0.77, 95% CI 0.68-0.87), and women in Scotland (aOR 0.60, 95% CI 0.46-0.78, comparing women in Scotland and England). One-year referral rate was 34.0% and the pattern of associations with patient characteristics was almost the same as for 30-day referrals.
CONCLUSIONS
About one in four women with urinary incontinence were referred to specialist secondary care services within one month after a UI diagnosis and one in three within one year. Referral rates decreased with age which confirms concerns that older women with UI are less likely to receive care according to existing clinical guidelines. Referral rates were also lower in women from minority-ethnic backgrounds. These finding may reflect clinicians' beliefs about the appropriateness of referral, differences in women's preferences for treatment, or other factors leading to inequities in referral for urinary incontinence.

Identifiants

pubmed: 33066730
doi: 10.1186/s12875-020-01282-y
pii: 10.1186/s12875-020-01282-y
pmc: PMC7568393
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

211

Subventions

Organisme : Department of Health
ID : 14/70/162
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : 14/70/162
Pays : International

Références

Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
JAMA. 2017 Oct 24;318(16):1592-1604
pubmed: 29067433
BJOG. 2011 Dec;118(13):1592-600
pubmed: 21895954
Int Urogynecol J. 2012 Aug;23(8):1087-93
pubmed: 22527544
Stat Med. 2007 May 20;26(11):2389-430
pubmed: 17031868
BMJ. 1988 Nov 5;297(6657):1187-9
pubmed: 3144344
Am J Manag Care. 2002 Dec;8(19 Suppl):S598-607
pubmed: 12516954
BMJ Open. 2013 Sep 13;3(9):e003389
pubmed: 24038008
PLoS One. 2014 Jun 18;9(6):e99825
pubmed: 24941260
Ther Adv Drug Saf. 2012 Apr;3(2):89-99
pubmed: 25083228
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Obstet Gynecol. 1997 Apr;89(4):501-6
pubmed: 9083302
Neurourol Urodyn. 2012 Apr;31(4):470-4
pubmed: 22378605
J Urol. 2006 Feb;175(2):601-4
pubmed: 16407004
Fam Pract. 1995 Mar;12(1):18-21
pubmed: 7665034
Cochrane Database Syst Rev. 2017 Jul 31;7:CD006375
pubmed: 28756647
Obstet Gynecol. 2014 Jan;123(1):141-8
pubmed: 24463674
Maturitas. 2005 Nov 30;52 Suppl 2:S3-12
pubmed: 16297578
Eur Urol. 2012 Jan;61(1):88-95
pubmed: 21831517
Neurourol Urodyn. 2009;28(4):288-94
pubmed: 19191259
Int Urogynecol J. 2010 Jan;21(1):5-26
pubmed: 19937315
Am J Manag Care. 2000 Jul;6(11 Suppl):S574-9
pubmed: 11183900
Neurourol Urodyn. 2018 Jan;37(1):501-509
pubmed: 28471525
Br J Clin Pharmacol. 2010 Jan;69(1):4-14
pubmed: 20078607
CMAJ. 2012 Aug 7;184(11):1265-9
pubmed: 22371511
BMJ Open. 2013 Jul 30;3(7):
pubmed: 23901026

Auteurs

Ipek Gurol-Urganci (I)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Centre for Quality Improvement and Clinical Audit, Royal College of Obstetricians and Gynaecologists, London, UK.

Rebecca S Geary (RS)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Centre for Quality Improvement and Clinical Audit, Royal College of Obstetricians and Gynaecologists, London, UK.

Jil B Mamza (JB)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.

Masao Iwagami (M)

Department of Health Services Research, University of Tsukuba, Tsukuba, Japan.
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Dina El-Hamamsy (D)

Leicester General Hospital, Women's and Children's Clinical Business Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.

Jonathan Duckett (J)

Medway NHS Foundation Trust, Gillingham, Kent, UK.

Andrew Wilson (A)

Department of Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.

Douglas Tincello (D)

Leicester General Hospital, Women's and Children's Clinical Business Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.
Department of Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.

Jan van der Meulen (J)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. jan.vandermeulen@lshtm.ac.uk.
Centre for Quality Improvement and Clinical Audit, Royal College of Obstetricians and Gynaecologists, London, UK. jan.vandermeulen@lshtm.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH